This past week’s pattern was a cluster of big-pharma and large healthcare collaborations that pull AI closer to multimodal biological and clinical data, and closer to lab and development workflows, with several deals pointing at “model plus measurement” loops.
Separately, a new benchtop sequencer announcement from San Diego kept the “falling sequencing …